{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:57:04Z","timestamp":1778860624947,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jiph.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T12:30:47Z","timestamp":1553085047000},"page":"656-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Increased CD5+ B-cells are associated with autoimmune phenomena in lepromatous leprosy patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Attia","family":"Kotb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itoh","family":"Kimito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waghi","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alamery","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2019.03.001_bib0005","first-page":"138","article-title":"CD5+ B cells ratio in lepromatous leprosy","volume":"3","author":"Ilhan","year":"2007","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jiph.2019.03.001_bib0010","series-title":"Rook\u2019s textbook of dermatology","first-page":"1","article-title":"Leprosy","author":"Lockwood","year":"2010"},{"key":"10.1016\/j.jiph.2019.03.001_bib0015","first-page":"255","article-title":"Classification of leprosy according to immunity \u2014 a five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.jiph.2019.03.001_bib0020","series-title":"Fitzpatrick\u2019s dermatology in general medicine","first-page":"1786","article-title":"Leprosy","author":"Rea","year":"2008"},{"key":"10.1016\/j.jiph.2019.03.001_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/181089","article-title":"Leprosy: an overview of pathophysiology","author":"Bhat","year":"2012","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.jiph.2019.03.001_bib0030","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science\/1109759","article-title":"On the origin of leprosy","volume":"308","author":"Monot","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jiph.2019.03.001_bib0035","first-page":"59","article-title":"Study of 622 new leprosy patients detected over a period of twelve years (1994\u20132005) in Tanta university hospital, Gharbia, Egypt","volume":"18","author":"Ramadan","year":"2007","journal-title":"J Pan Ar League Dermatol"},{"issue":"3","key":"10.1016\/j.jiph.2019.03.001_bib0040","first-page":"770","article-title":"Leprosy: disease prevailing from past to present","volume":"2","author":"Rao","year":"2012","journal-title":"Int J Res Phar Chem"},{"key":"10.1016\/j.jiph.2019.03.001_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cyto.2016.12.011","article-title":"Increased IL-35 producing Tregs and CD19+IL-35+ cells are associated with disease progression in leprosy patients","volume":"91","author":"Mohd","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jiph.2019.03.001_bib0050","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2018.00604","article-title":"Emerging concepts of adaptive immunity in leprosy","volume":"9","author":"Sadhu","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jiph.2019.03.001_bib0055","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2353\/ajpath.2007.061279","article-title":"CD19 expression in B cells is important for suppression of contact hypersensitivity","volume":"171","author":"Watanabe","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jiph.2019.03.001_bib0060","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/T5EM9BQUB9CM8F57","article-title":"Flow cytometric analysis of CD5+ B cells","volume":"121","author":"Gupta","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jiph.2019.03.001_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.08.010","article-title":"Regulatory B cells in skin and connective tissue diseases","volume":"60","author":"Fujimoto","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jiph.2019.03.001_bib0070","series-title":"Guidelines for the control of leprosy in the Northern territory","first-page":"16","author":"Coates","year":"2010"},{"key":"10.1016\/j.jiph.2019.03.001_bib0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cellimm.2013.02.003","article-title":"Regulatory B cells in autoimmune diseases","volume":"10","author":"Min","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jiph.2019.03.001_bib0080","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1177\/0961203312460901","article-title":"B lymphocytes in nonorgan-specific autoimmune diseases: implications for therapy","volume":"21","author":"Youinou","year":"2012","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.jiph.2019.03.001_bib0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.autrev.2007.02.013","article-title":"Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings","volume":"7","author":"Ferraccioli","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jiph.2019.03.001_bib0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM197305172882001","article-title":"B lymphocytes in lepromatous leprosy","volume":"288","author":"Gajl-Peczalska","year":"1973","journal-title":"New England J Med"},{"key":"10.1016\/j.jiph.2019.03.001_bib0095","first-page":"23","article-title":"T and B lymphocytes in patients with lepromatous leprosy","volume":"16","author":"Mendes","year":"1974","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jiph.2019.03.001_bib0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/pr.109.002006","article-title":"Therapeutic targeting of B cells for rheumatic autoimmune diseases","volume":"63","author":"Engel","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.jiph.2019.03.001_bib0105","first-page":"487","article-title":"Autoantibodies in leprosy and leishmania patients \u2014 more evidence on the association of infections and autoimmunity","volume":"49","author":"Szyper-Kravitz","year":"2009","journal-title":"Bras J Rheumatol"},{"key":"10.1016\/j.jiph.2019.03.001_bib0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/art.1780330329","article-title":"B cells expressing CD5 in minor labial salivary glands of patients with primary Sjogren\u2019s syndrome","volume":"33","author":"Zeher","year":"1990","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jiph.2019.03.001_bib0115","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0168-8278(03)00122-3","article-title":"Expansion of CD5+ B cell overexpressing CD81 in HCV infection: towards better understanding the link between HCV infection, B cell activation and lymphoproliferation","volume":"38","author":"Zuckerman","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiph.2019.03.001_bib0120","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/art.20487","article-title":"B lymphocyte signalling pathways in systemic autoimmunity","volume":"50","author":"Zouali","year":"2004","journal-title":"Arthritis Rheumatol"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034119301108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034119301108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:04:55Z","timestamp":1761750295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034119301108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1876034119301108"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2019.03.001","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased CD5+ B-cells are associated with autoimmune phenomena in lepromatous leprosy patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}